GlassScriptPhysician profile
Michael Paul Mays
NPI 1780722322
$14,443.10
in general payments reported to CMS, 2019-2025
20 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $599 · 2021: $121 · 2022: $249 · 2024: $13K · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,075 · Travel and Lodging: $368 · Long Term Medical Supply Or Device Loan: $147 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $11,500.00 |
| Food and Beverage | $1,075.34 |
| Travel and Lodging | $368.07 |
| Long Term Medical Supply Or Device Loan | $146.68 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,840.27 | 2024 | |
| Galderma Laboratories, L.P. | $309.81 | 2019-2022 | |
| Merz North America, INC. | $244.08 | 2019-2020 | |
| Amgen INC. | $161.91 | 2020-2022 | |
| Integra Lifesciences Corporation | $146.68 | 2025 | Micromatrix |
| Abbvie INC. | $119.36 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $104.78 | 2019-2021 | |
| Lilly USA, LLC | $95.01 | 2019-2022 | |
| Janssen Biotech, INC. | $89.18 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $64.73 | 2025 | Acthar |
| Ucb, INC. | $42.35 | 2019-2020 | |
| Dermira, INC. | $38.32 | 2019-2020 | |
| Almirall LLC | $33.66 | 2019-2021 | |
| Pfizer INC. | $33.45 | 2019-2020 | |
| Revance Therapeutics, INC. | $24.75 | 2024 | Daxxify |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $22.40 | 2025 | |
| Alpha Orthopedic Systems | $19.48 | 2020 | |
| Incyte Corporation | $18.26 | 2021 | |
| Davol INC. | $17.36 | 2020 | |
| Medtronic Vascular, INC. | $17.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mays listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.